comparemela.com

Latest Breaking News On - Sagimet biosciences company profile - Page 1 : comparemela.com

Sagimet Biosciences (NASDAQ:SGMT) Earns Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a research report released on Friday morning, Benzinga reports. The brokerage currently has a $32.00 target price on the stock. Several other brokerages also recently issued reports on SGMT. Leerink Partnrs reissued an outperform rating on shares of Sagimet […]

United-states
New-york
American
Sagimet-biosciences
Leerink-partnrs
David-happel
Goldman-sachs-group
Securities-exchange-commission
Shaughnessy-asset-management
Sagimet-biosciences-company-profile
Sagimet-biosciences-inc
American-international-group-inc

Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Rating of "Buy" by Analysts

Sagimet Biosciences Inc. (NASDAQ:SGMT – Get Free Report) has earned a consensus rating of “Buy” from the seven research firms that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock […]

United-states
Leerink-partnrs
David-happel
Sagimet-biosciences
Hermes-inc
Silverarc-capital-management
Nasdaq
Sagimet-biosciences-inc
Platinum-investment-management-ltd
Sagimet-biosciences-company-profile
Goldman-sachs-group
Get-free-report

Brokerages Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $41.50

Brokerages Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $41.50
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
David-happel
Leerink-partnrs
Sagimet-biosciences
Barclays-plc
Sagimet-biosciences-company-profile
Goldman-sachs-group
Sagimet-biosciences-inc
York-state-common-retirement-fund
Nasdaq
Virtu-financial

100,000 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Purchased by Silverarc Capital Management LLC

100,000 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Purchased by Silverarc Capital Management LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Texas
United-states
Sagimet-biosciences
Goldman-sachs-group
Sagimet-biosciences-company-profile
Victory-capital-management-inc
Charles-schwab-investment-management-inc
Platinum-investment-management-ltd
Nasdaq
Sagimet-biosciences-inc
Silverarc-capital-management
Free-report

JMP Securities Boosts Sagimet Biosciences (NASDAQ:SGMT) Price Target to $47.00

JMP Securities Boosts Sagimet Biosciences (NASDAQ:SGMT) Price Target to $47.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Texas
Sagimet-biosciences
Sagimet-biosciences-inc
Charles-schwab-investment-management-inc
Victory-capital-management-inc
York-state-common-retirement-fund
Platinum-investment-management-ltd
Sagimet-biosciences-company-profile
Get-free-report
Retirement-system

vimarsana © 2020. All Rights Reserved.